GSK launches new rare disease research unit
05 February 2010
Simon Varcoe
Please Login to read the full article.
05 February 2010
Simon Varcoe
simon.varcoe@informa.com
GlaxoSmithKline has formed a new standalone unit to develop treatments for rare diseases.
GSK's president of Asia Pacific and chairman of Japan
Marc Dunoyer will lead the new operation and will work closely with the company's senior vice-president of drug discovery
Patrick Vallance. The...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Celgene Pays Acceleron $25M up front under anaemia drug partnership
- AVI BioPharma raises $30M to finance lead DMD candidate
- Prosensa/GSK hopes for Phase III DMD recruitment boost from published data
- PhRMA reports record number of rare disease drug candidates under development
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
